Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-06-24 @ 5:32 AM
Study NCT ID:
NCT01278160
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2011-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
Sponsor:
Novo Nordisk A/S
Organization: